Treatment of diabetes mellitus by long-acting formulations of insulins Grant US-11191722-B2 United States of America 07 Dec 2021
Medical device and method for glycemic control Grant US-11166650-B2 United States of America 09 Nov 2021
Medical device and method for providing information for glycemic control Grant US-11135367-B2 United States of America 05 Oct 2021
Treatment type 2 diabetes mellitus patients Grant US-10434147-B2 United States of America 08 Oct 2019
Treatment of type 2 diabetes mellitus patients Grant US-10159713-B2 United States of America 25 Dec 2018
Combination of an insulin and a GLP-1 agonist Grant US-10117909-B2 United States of America 06 Nov 2018
Treatment of diabetes mellitus by long-acting formulations of insulins Grant US-10092513-B2 United States of America 09 Oct 2018
Pharmaceutical composition comprising a GLP-1 agonist, an insulin and methionine Grant US-10029011-B2 United States of America 24 Jul 2018
Pharmaceutical composition comprising a GLP-1-agonist and methionine Grant US-10028910-B2 United States of America 24 Jul 2018
Pharmaceutical composition for use in the treatment of a neurodegenerative disease Grant US-9987332-B2 United States of America 05 Jun 2018
Use of AVE0010 for the treatment of diabetes mellitus type 2 Grant US-9981013-B2 United States of America 29 May 2018
Insulin glargine/lixisenatide fixed ratio formulation Grant US-9950039-B2 United States of America 24 Apr 2018
Pharmaceutical combination for improving glycemic control as add-on therapy to basal… Grant US-9821032-B2 United States of America 21 Nov 2017
Pharmaceutical composition comprising a GLP-1 agonist and methionine Grant US-9707176-B2 United States of America 18 Jul 2017
Combination of an insulin and a GLP-1-agonist Grant US-9526764-B2 United States of America 27 Dec 2016
Pharmaceutical combination for use in glycemic control in diabetes type 2 patients Grant US-9408893-B2 United States of America 09 Aug 2016
Pharmaceutical composition for use in the treatment of a neurodegenerative disease Grant US-9364519-B2 United States of America 14 Jun 2016
Medical system and method for providing glycemic control based on glycemic response… Grant US-8660802-B2 United States of America 25 Feb 2014
PHARMACEUTICAL COMBINATION FOR USE IN GLYCEMIC CONTROL IN DIABETES TYPE 2 PATIENTS Application US-20130203666-A1 United States of America 08 Aug 2013
TREATMENT PROTOCOL OF DIABETES TYPE 2 Application WO-2013060850-A1 World Intellectual Property Organisation (WIPO) 02 May 2013